Hypera S.A. (HYPMY)
OTCMKTS · Delayed Price · Currency is USD
4.220
-0.180 (-4.09%)
Aug 7, 2025, 3:58 PM EDT
Hypera Revenue
Hypera had revenue of 2.15B BRL in the quarter ending June 30, 2025, a decrease of -1.60%. This brings the company's revenue in the last twelve months to 6.66B, down -16.74% year-over-year. In the year 2024, Hypera had annual revenue of 7.44B, down -5.97%.
Revenue (ttm)
6.66B BRL
Revenue Growth
-16.74%
P/S Ratio
2.29
Revenue / Employee
635.60K BRL
Employees
10,481
Market Cap
2.80B USD
Revenue Chart
* This company reports financials in BRL.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.44B | -472.19M | -5.97% |
Dec 31, 2023 | 7.91B | 368.30M | 4.88% |
Dec 31, 2022 | 7.55B | 1.61B | 27.10% |
Dec 31, 2021 | 5.94B | 1.85B | 45.21% |
Dec 31, 2020 | 4.09B | 794.12M | 24.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Spruce Biosciences | 2.91M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Hypera News
- 4 weeks ago - Brazil's Hypera announces new majority stakeholder group - Reuters
- 4 months ago - Hypera S.A. (HYPMY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Hypera: Short-Term Pain For Long-Term Gain - Seeking Alpha
- 5 years ago - Hypera S.A.: Adding The Brazilian Pharma To Your Portfolio - Seeking Alpha
- 5 years ago - A Brazilian-Focused Dividend Portfolio - Seeking Alpha